Radiation Dermatitis Clinical Trials

10 recruiting

Radiation Dermatitis Trials at a Glance

12 actively recruiting trials for radiation dermatitis are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Chengdu, Toronto, and Jinan. Lead sponsors running radiation dermatitis studies include West China Hospital, Sunnybrook Health Sciences Centre, and National University Hospital, Singapore.

Browse radiation dermatitis trials by phase

Treatments under study

About Radiation Dermatitis Clinical Trials

Looking for clinical trials for Radiation Dermatitis? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Radiation Dermatitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Radiation Dermatitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

ROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer

Radiation Dermatitis
West China Hospital40 enrolled1 locationNCT07081074
Recruiting
Not Applicable

ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer

Radiation Dermatitis
West China Hospital5 enrolled1 locationNCT07086638
Recruiting
Not Applicable

Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin

Acute Radiation DermatitisRectal Cancer, RadiotherapyAnal Pain+1 more
Qianfoshan Hospital274 enrolled1 locationNCT06837831
Recruiting
Not Applicable

M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis

Radiation Dermatitis
Wake Forest University Health Sciences16 enrolled1 locationNCT06441266
Recruiting
Not Applicable

Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis

Acute Radiation Dermatitis
University of the Philippines54 enrolled1 locationNCT05079763
Recruiting
Not Applicable

Novel ROS-scavenging Nanoenzymes for the Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer

Radiation Dermatitis
West China Hospital30 enrolled1 locationNCT07064577
Recruiting
Phase 3

Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer

Breast CancerSkin MicrobiomeRadiation Dermatitis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University326 enrolled1 locationNCT07066280
Recruiting
Phase 3

Topical Betamethasone Versus Moisturizer in Preventing Radiation Dermatitis in Large-Breasted Patients Treated in the Prone Position

Breast CancerRadiation Dermatitis
Sunnybrook Health Sciences Centre276 enrolled1 locationNCT06915857
Recruiting

Prospective Assessment of Acute Skin Toxicities in Breast Cancer Patients Undergoing Retreatment with 40 Gy in 15 Fractions Radiation Therapy

Breast CancerRadiation Dermatitis
Sunnybrook Health Sciences Centre30 enrolled1 locationNCT06729814
Recruiting
Not Applicable

StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients

Acute Radiation DermatitisHead and Neck Cancers
National University Hospital, Singapore100 enrolled1 locationNCT03394417
Recruiting
Not Applicable

Epidermal Skin Grafts to Improve Healing In Radiation Wounds

Radiation Dermatitis
Massachusetts General Hospital34 enrolled1 locationNCT04560803
Recruiting

The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients

Breast CancerSkin MicrobiomeRadiation Dermatitis+1 more
Fudan University100 enrolled1 locationNCT05032768